*Department of Dermatology, University of Florida College of Medicine, Gainesville, FL †Miraca Life Sciences Research Institute, Irving, TX ‡Miraca Life Sciences Research Institute, Newton, and Department of Dermatology at Tufts Medical Center, Boston, MA.
Adv Anat Pathol. 2017 Jul;24(4):171-194. doi: 10.1097/PAP.0000000000000157.
Cutaneous squamous cell carcinoma is the second most common form of nonmelanoma skin cancer after basal cell carcinoma and accounts for the majority of nonmelanoma skin cancer-related deaths. In 2017, the American Joint Committee on Cancer revised the staging guidelines of cutaneous squamous cell carcinoma to reflect recent evidence concerning high-risk clinicopathologic features. This update reviews the literature on prognostic features and staging, including the eighth edition of the American Joint Committee on Cancer Staging Manual. A wide range of histopathologic variants of cutaneous squamous cell carcinoma exists, several of which are associated with aggressive behavior. A review of cutaneous squamous cell carcinoma variants, emphasizing diagnostic pitfalls, immuhistochemical findings and prognostic significance, is included. Of note, the eighth edition of the American Joint Committee on Cancer Staging Manual refers to squamous cell carcinoma of the head and neck only.
皮肤鳞状细胞癌是继基底细胞癌之后第二常见的非黑色素瘤皮肤癌,占非黑色素瘤皮肤癌相关死亡的大多数。2017 年,美国癌症联合委员会修订了皮肤鳞状细胞癌的分期指南,以反映有关高危临床病理特征的最新证据。本更新回顾了关于预后特征和分期的文献,包括第八版美国癌症联合委员会分期手册。皮肤鳞状细胞癌存在广泛的组织病理学变异,其中一些与侵袭性行为有关。本文回顾了皮肤鳞状细胞癌的变异,强调了诊断陷阱、免疫组织化学发现和预后意义。值得注意的是,第八版美国癌症联合委员会分期手册仅指头颈部鳞状细胞癌。